首页 | 本学科首页   官方微博 | 高级检索  
检索        

降尿酸治疗对肾脏保护作用的研究进展
引用本文:辛雷,梁菁菁,高颖,徐霞,赵东宝.降尿酸治疗对肾脏保护作用的研究进展[J].中国全科医学,2019,22(17):2025-2029.
作者姓名:辛雷  梁菁菁  高颖  徐霞  赵东宝
作者单位:200433上海市,海军军医大学附属长海医院风湿免疫科
*通信作者:赵东宝,教授;E-mail:dongbaozhao@163.com
基金项目:基金项目:国家自然科学基金资助项目(81471607,81671595)
摘    要:痛风患者常出现并发症,如心血管系统疾病、肾功能不全和代谢综合征等。部分研究认为高尿酸血症和痛风会增加慢性肾脏病的风险。因此,降尿酸治疗对于慢性肾脏病的影响研究非常重要。目前 ,降尿酸治疗对慢性肾脏病的影响尚不明确,部分随机对照研究发现别嘌醇可以减缓肾功能的恶化,而非布司他的相关研究目前存在争议,并且缺乏苯溴马隆在慢性肾脏病方面的高质量研究。今后,仍需在降尿酸治疗的肾脏保护方面进行更多的研究。

关 键 词:痛风  降尿酸治疗  别嘌醇  非布司他  苯溴马隆  肾功能  

Research Advance of Urate-lowering Therapy on Kidney Protection
XIN Lei,LIANG Jingjing,GAO Ying,XU Xia,ZHAO Dongbao.Research Advance of Urate-lowering Therapy on Kidney Protection[J].Chinese General Practice,2019,22(17):2025-2029.
Authors:XIN Lei  LIANG Jingjing  GAO Ying  XU Xia  ZHAO Dongbao
Institution:Department of Rheumatology and Immunology,Changhai Hospital Affiliated to Naval Military Medical University,Shanghai 200433,China
*Corresponding author:ZHAO Dongbao,Professor;E-mail:dongbaozhao@163.com
Abstract:Patients with gout often have some complications,such as cardiovascular diseases,chronic kidney diseases,and metabolic syndrome.Some studies suggested that hyperuricemia and gout increased the risk of chronic kidney diseases.Therefore,it is important to research on the effect of urate-lowering therapy on chronic kidney disease.At present,the effect of urate-lowering therapy on chronic kidney disease is not yet clear.Some randomized controlled studies have found that allopurinol can slow down the deterioration of renal function.The current research on febuxostat is controversial and we are lack of high quality research of benzbromarone in treatment of chronic kidney diseases.In the future,more studies are still needed on kidney protection by urate-lowering therapy.
Keywords:Gout  Urate-lowering therapy  Allopurinol  Febuxostat  Benzbromarone  Renal function  
点击此处可从《中国全科医学》浏览原始摘要信息
点击此处可从《中国全科医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号